Evidence map›Paper›PMID 19386588›Full record

ArticleThe Journal of biological chemistry2009

MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN).

Rocio T Martinez-Nunez, Fethi Louafi, Peter S Friedmann, Tilman Sanchez-Elsner

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it, 211 citations in OpenAlex.

  1. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Epigenetic basis of diabetic vasculopathy.Frontiers in endocrinology · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rocio T Martinez-NunezFrom the Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, Southampton SO16 6YD, United Kingdom.
Fethi LouafiFrom the Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, Southampton SO16 6YD, United Kingdom.
Peter S FriedmannFrom the Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, Southampton SO16 6YD, United Kingdom.
Tilman Sanchez-ElsnerFrom the Division of Infection, Inflammation and Repair, University of Southampton School of Medicine, Southampton SO16 6YD, United Kingdom; Southampton General Hospital, Southampton SO16 6YD, United Kingdom. Electronic address: T.Sanchez-Elsner@soton.ac.uk.
University of Southampton · GBSouthampton General Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA-155 (miR-155) has been involved in the response to inflammation in macrophages and lymphocytes. Here we show how miR-155 participates in the maturation of human dendritic cells (DC) and modulates pathogen binding by down-regulating DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), after directly targeting the transcription factor PU.1. During the maturation of DCs, miR-155 increases up to 130-fold, whereas PU.1 protein levels decrease accordingly. We establish that human PU.1 is a direct target for miR-155 and localize the target sequence for miR-155 in the 3'-untranslated region of PU.1. Also, overexpression of miR-155 in the THP1 monocytic cell line decreases PU.1 protein levels and DC-SIGN at both the mRNA and protein levels. We prove a link between the down-regulation of PU.1 and reduced transcriptional activity of the DC-SIGN promoter, which is likely to be the basis for its reduced mRNA expression, after miR-155 overexpression. Finally, we show that, by reducing DC-SIGN in the cellular membrane, miR-155 is involved in regulating pathogen binding as dendritic cells exhibited the lower binding capacity for fungi and HIV protein gp-120 when the levels of miR-155 were higher. Thus, our results suggest a mechanism by which miR-155 regulates proteins involved in the cellular immune response against pathogens that could have clinical implications in the way pathogens enter the human organism.

Indexed as

3' Untranslated RegionsCandida albicansCandidiasisCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinDendritic CellsDown-RegulationGene Expression RegulationHeLa CellsHIV Envelope Protein gp120HIV InfectionsHumansLectins, C-TypeMicroRNAsProto-Oncogene ProteinsProto-Oncogene Protein Spi-13' Untranslated RegionsCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing Nonintegringp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Lectins, C-TypeMicroRNAsMIRN155 microRNA, humanProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Receptors, Cell SurfaceTrans-Activators

Identifiers

PMID19386588
PMCPMC2713543
OpenAlexW2039342473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.